TheEdgeResearch
Home / Stocks / ILMN

Illumina, Inc. (ILMN)

NASDAQ Healthcare Medical - Diagnostics & Research
$177.18 ▲ +0.36%
Market Cap
$26.81B
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Beta
1.49
52-Wk Range
88-182.84
CEO
Jacob Thaysen
Country
US
Currency
USD

Illumina, Inc. specializes in delivering advanced genetic and genomic analysis tools, primarily through sequencing and array technologies. The company's offerings empower clients across various sectors to integrate genomic insights into both research and clinical environments, with applications spanning critical fields like life sciences, cancer diagnostics, reproductive health, agriculture, and innovative new domains. Illumina's portfolio encompasses specialized instrumentation and necessary consumables for genetic analysis, alongside comprehensive genotyping and sequencing services. They als…

Open full interactive analysis & DCF →